BRCA1 and cancer: The aberrant BRCA1 promoter methylation is found in approximately one-ninth of ovarian cancer tumors (45–47) and in one-fourth of breast basal-like tumors (48), suggesting that BRCA1 silencing is considered a leading non-genetic case of BRCA1 inactivation in sporadic wild-type BRCA cancer.